1. Home
  2. RMR vs MDWD Comparison

RMR vs MDWD Comparison

Compare RMR & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RMR Group Inc.

RMR

The RMR Group Inc.

HOLD

Current Price

$16.15

Market Cap

253.9M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.50

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMR
MDWD
Founded
1986
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.9M
224.6M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
RMR
MDWD
Price
$16.15
$16.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$17.00
$36.00
AVG Volume (30 Days)
149.1K
72.9K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
11.06%
N/A
EPS Growth
N/A
N/A
EPS
0.71
N/A
Revenue
$700,284,000.00
N/A
Revenue This Year
$274.80
$57.63
Revenue Next Year
$3.85
$26.44
P/E Ratio
$22.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.48
$14.14
52 Week High
$18.09
$22.51

Technical Indicators

Market Signals
Indicator
RMR
MDWD
Relative Strength Index (RSI) 44.80 40.10
Support Level $15.81 $16.33
Resistance Level $16.84 $18.58
Average True Range (ATR) 0.47 0.57
MACD -0.09 -0.07
Stochastic Oscillator 14.68 7.67

Price Performance

Historical Comparison
RMR
MDWD

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: